Bacteriophage and antibacterial composition comprising the same

US9657277B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9657277-B2
Application numberUS-201414770429-A
CountryUS
Kind codeB2
Filing dateFeb 24, 2014
Priority dateFeb 27, 2013
Publication dateMay 23, 2017
Grant dateMay 23, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a novel bacteriophage ΦCJ19 (KCCM11361P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ΦCJ19 (KCCM11361P) as an active ingredient. Further, the present invention is a method of preventing and/or treating infectious diseases by enterotoxigenic Escherichia coli in animals except for humans using the bacteriophage ΦCJ19 (KCCM11361P) or the antibacterial composition containing the bacteriophage ΦCJ19 (KCCM11361P) as an active ingredient.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of preparing an animal feed composition, the method comprising: providing a bacteriophage composition comprising a bacteriophage having the nucleic acid sequence of SEQ ID No: 1; and mixing the composition with an animal feed base to provide the animal feed composition such that the bacteriophage is in an amount of 1×10 6 to 5×10 12 PFU/ml with reference to the total amount of the animal feed composition. 2. The method of claim 1 , further comprising: mixing, with the animal feed base, one or more additives selected from the group consisting of an amino acid, a vitamin, an enzyme, a probiotic, a flavoring agent, a non-protein nitrogen compound, a silicate, a buffer, a coloring agent, an extractant and an oligosaccharide. 3. A method of feeding, the method comprising: preparing the animal feed composition according to the method of claim 1 ; and feeding, to an animal, the animal feed composition as a feed. 4. A method of preparing a drinking water composition, the method comprising: providing a bacteriophage composition comprising a bacteriophage having the nucleic acid sequence of SEQ ID No: 1; and mixing the composition with drinking water to provide the drinking water composition such that the bacteriophage is in an amount of 1×10 6 to 5×10 12 PFU/ml with reference to the total amount of the drinking water composition. 5. The method of claim 4 , further comprising: mixing, with the animal feed base, one or more additives selected from the group consisting of an amino acid, a vitamin, an enzyme, a probiotic, a flavoring agent, a non-protein nitrogen compound, a silicate, a buffer, a coloring agent, an extractant and an oligosaccharide. 6. A method of feeding, the method comprising: preparing the drinking water composition according to the method of claim 4 ; and feeding, to an animal, the drinking water composition as drinking water. 7. A method of treating an infectious disease caused by ETEC, the method comprising: administering a bacteriophage composition to a subject in need of such treatment, wherein the bacteriophage composition comprises a pharmaceutically acceptable carrier and a bacteriophage having the nucleic acid sequence of SEQ ID No: 1 in an amount of 1×10 6 to 5×10 12 PFU/ml with reference to the total amount of the bacteriophage composition. 8. A method of claim 7 , wherein the infectious disease is colibacillosis. 9. A method of retarding progress of an infectious disease caused by ETEC, the method comprising: feeding an animal feed composition to an animal, wherein the animal feed composition comprising an animal feed base and a bacteriophage having the nucleic acid sequence of SEQ ID No: 1 in an amount of 1×10 6 to 5×10 12 PFU/ml with reference to the total amount of the animal feed composition. 10. A method of claim 9 , wherein the infectious disease is colibacillosis.

Assignees

Inventors

Classifications

  • Uses of virus other than therapeutic or vaccine, e.g. disinfectant · CPC title

  • for swines · CPC title

  • Antibiotics · CPC title

  • Viruses; Subviral particles; Bacteriophages · CPC title

  • Antibacterial agents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9657277B2 cover?
Provided is a novel bacteriophage ΦCJ19 (KCCM11361P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ΦCJ19 (KCCM11361P) as an active ingredient. Further, the present invention is a method of preventing and/or treating infectious diseases by enterotoxigenic Escherichia coli in animals except for humans using the bacteriophage ΦCJ19 (KCCM1…
Who is the assignee on this patent?
Cj Cheiljedang Corp
What technology area does this patent fall under?
Primary CPC classification C12N7/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).